Immunohistochemical studies have associated ROR1 expression in DLBCL with poor prognosis subgroups, such as primary refractory DLBCL and Richter’s syndrome, while its expression is less frequent in de novo non-relapsed DLBCL [88]. The gene discussed is ROR1; the disease is diffuse large B-cell lymphoma.